首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Tetracycline-Inducible Expression of Individual Secreted Aspartic Proteases in Candida albicans Allows Isoenzyme-Specific Inhibitor Screening
【2h】

Tetracycline-Inducible Expression of Individual Secreted Aspartic Proteases in Candida albicans Allows Isoenzyme-Specific Inhibitor Screening

机译:四环素诱导的白色念珠菌中分泌的天冬氨酸蛋白酶的表达允许同工酶特异性抑制剂筛选。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The yeast Candida albicans possesses a gene family that encodes secreted aspartic proteases (Saps), which are important for the virulence of this human fungal pathogen. Inhibitors of the Saps could therefore be used as novel antimycotic agents for the treatment of C. albicans infections. In the present study, we established a bioassay which allows testing of the activity of potential protease inhibitors against specific Sap isoenzymes by their ability to inhibit protease-dependent growth of C. albicans. In a medium containing bovine serum albumin (BSA) as the sole source of nitrogen, C. albicans specifically expresses the Sap2p isoenzyme, which degrades the BSA and thereby enables the fungus to grow. As the other SAP genes are not significantly expressed under these conditions, mutants lacking SAP2 are unable to utilize BSA as a nitrogen source and cannot grow in such a medium. To investigate whether forced expression of SAP genes other than SAP2 would also allow growth on BSA, we constructed a set of strains expressing each of the 10 SAP genes from a tetracycline-inducible promoter in a sap2Δ mutant background. Expression of Sap1p, Sap2p, Sap3p, Sap4p, Sap5p, Sap6p, Sap8p, and a C-terminally truncated, secreted Sap9p restored the growth of the sap2Δ mutant with different efficiencies. This set of strains was then used to test the activities of various aspartic protease inhibitors against specific Sap isoenzymes by monitoring growth on BSA in the presence of the inhibitors. While pepstatin blocked the activity of all of the Saps tested, the human immunodeficiency virus protease inhibitors ritonavir and saquinavir inhibited growth of the strains expressing Sap1p to Sap3p and Sap1p, respectively, but not that of strains expressing other Saps. Therefore, the strain set can be used to test the activity of new protease inhibitors against individual C. albicans Sap isoenzymes by their ability to block the growth of the pathogen.
机译:酵母白色念珠菌拥有一个基因家族,该家族编码分泌的天冬氨酸蛋白酶(Saps),这对于这种人类真菌病原体的毒力很重要。因此,Sap抑制剂可以用作治疗白色念珠菌感染的新型抗真菌剂。在本研究中,我们建立了一种生物测定法,该测定法可以通过抑制白念珠菌蛋白酶依赖性生长的能力来测试针对特定Sap同工酶的潜在蛋白酶抑制剂的活性。在含有牛血清白蛋白(BSA)作为唯一氮源的培养基中,白色念珠菌特异性表达Sap2p同工酶,该酶降解BSA,从而使真菌得以生长。由于其他SAP基因在这些条件下未显着表达,因此缺少SAP2的突变体无法利用BSA作为氮源,也无法在这种培养基中生长。为了研究SAP2以外的SAP基因的强制表达是否也能在BSA上生长,我们构建了一组在sap2Δ突变体背景下从四环素诱导型启动子表达10个SAP基因的菌株。 Sap1p,Sap2p,Sap3p,Sap4p,Sap5p,Sap6p,Sap8p和C端截短,分泌的Sap9p的表达恢复了具有不同效率的sap2Δ突变体的生长。然后通过监测在抑制剂存在下在BSA上的生长,将这组菌株用于测试各种天冬氨酸蛋白酶抑制剂对特定Sap同工酶的活性。胃酶抑素阻断了所有测试的Saps的活性,而人类免疫缺陷病毒蛋白酶抑制剂ritonavir和saquinavir分别抑制了表达Sap1p的菌株对Sap3p和Sap1p的生长,但不抑制表达其他Saps的菌株的生长。因此,该菌株组可用于通过其阻断病原体生长的能力来测试新型蛋白酶抑制剂针对各个白色念珠菌汁液同工酶的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号